en · de · es
sr9009-notes.peptides1004.com › Data › Analytical Detection And Laboratory Handling — Deep Dive

Analytical Detection And Laboratory Handling — Deep Dive

By Editorial Desk · published 2025-11-20 · last reviewed 2025-12-28 · Data

Everything below concerns certificate of analysis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2025-12-28. Where a claim depends on a specific study, the study is described rather than over-claimed.

Analytical Detection and Laboratory Handling

Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

SR9009 Background and Mechanism

Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.

Sr9009 at a glance

PropertyValueNotes
AppearanceOff-white to pale yellow solidVisual description varies with purity and source
SolubilitySoluble in DMSO and ethanol; poorly soluble in waterOrganic stock solutions are common in research
Typical storage-20 °C, desiccated, protected from lightAvoid repeated freeze-thaw cycles
Typical analytical methodLC-MS or HPLC-UVReference standards are needed for quantification
Molar massApproximately 437.9 g/molCalculated from the reported free-base formula

Analytical Detection and Storage

Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.

Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.

Related pages on this site

Background and Research Status

REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.

Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.

SR9009 Handling and Quality Control

SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.

SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.

Supporting material

=== Phosphorus-33 === Phosphorus-33 is a radioactive isotope of phosphorus; it is produced from sulfur-33. is a pure β-emitter, like 32P, and can be used as an alternative to it in research in molecular biology. Indeed, its longer half-life and especially its lower decay energy make its manipulation simpler in the laboratory. In the medical field, 33P has been used in the treatment of arterial stenosis but is no longer indicated at this time.

In 1970, the focus of Freeman's research became protein crystallography and he turned his attention to the blue copper proteins (cupredoxins) and particularly the electron transport protein plastocyanin. The intensely blue colour of plastocyanin and its unusual redox properties had frustrated all attempts to synthesise a small molecule mimic. It was not until 1977 that his group finally determined the structure of plastocyanin crystallised from the poplar tree (see diagram at right); this was the first protein crystal structure determined in the Southern Hemisphere. Together with subsequent work in collaboration with Ed Solomon, this work led to understanding of the unusual geometry of the copper metal site (see diagram at left) as well as the spectroscopic and electrochemical properties characteristic of blue copper proteins. Later in his career, Freeman developed an interest in the applications of EXAFS spectroscopy to metalloprotein structure, collaborating with both James Penner-Hahn and Keith Hodgson. Working together, the Freeman and Hodgson groups were, in 1988, the first to determine a new crystal structure of a protein using the multiple wavelength anomalous dispersion (MAD) method. Throughout his career, Freeman was concerned about the influence of the tyranny of distance on the development of Australian science. For this reason, in 1972 Freeman and Alexander Boden AO, FAA, founded the Foundation for Inorganic Chemistry at the university to bring international scholars to the department to deliver a course for graduate students and give seminars for faculty.

=== Gómez, France 1998 and the end of the cycle (1995–1999) === Hernán Darío Gómez, known as El Bolillo, replaced Maturana in 1995. Colombia lost 2–0 to the hosts Uruguay in the semi-finals of the 1995 Copa América before beating the United States 4–1 in Maldonado to take third place, Wilmer Cabrera, Valderrama, Asprilla and Rincón all scoring. Two years later they were eliminated 2–1 by the hosts Bolivia in the quarter-finals of the 1997 Copa América. Colombia reached the 1998 FIFA World Cup by finishing third in the first CONMEBOL qualifying tournament contested as a single home-and-away league, taking 28 points from sixteen matches — two behind Argentina and one behind Paraguay — with Asprilla their leading scorer on seven goals, including a hat-trick in a 4–1 win over Chile in Barranquilla. Drawn in Group G with Tunisia, England and Romania, they lost 1–0 to Romania, beat Tunisia 1–0, and were eliminated on 26 June by England at the Stade Bollaert-Delelis in Lens. Darren Anderton volleyed England ahead in the 20th minute and David Beckham curled in a free kick from some 30 yards nine minutes later for his first international goal, Faryd Mondragón keeping the margin to 2–0 thereafter.

Surface charge practically always appears on the particle surface when it is placed into a fluid. Most fluids contain ions, positive (cations) and negative (anions). These ions interact with the object surface. This interaction might lead to the adsorption of some of them onto the surface. If the number of adsorbed cations exceeds the number of adsorbed anions, the surface would have a net positive electric charge. Dissociation of the surface chemical group is another possible mechanism leading to surface charge.

Für Sebastian Wedler (1919) 6 Studies for string quartet (1920) Piano piece (1921) String quartet (1921) 3 stories by Theodor Däubler for female chorus (1923–1945) 2 Pieces for string quartet, Op. 2 (1925/26) 7 short works for orchestra, Op. 4 (1929) 3 Short Pieces for piano (1934) 2 songs for voice & orchestra after Mark Twain's "Indian Joe" (1932/33) Kinderjahr – Six Piano pieces from op. 68 of Robert Schumann (1941) 2 songs with orchestra

Sources: en.wikipedia.org

Supporting material

The mechanism involves oxidation of the selenol of a selenocysteine residue by hydrogen peroxide. This process gives the derivative with a selenenic acid (RSeOH) group. The selenenic acid is then converted back to the selenol by a two step process that begins with reaction with glutathione (GSH) to form the GS-SeR and water. A second GSH molecule reduces the GS-SeR intermediate back to the selenol, releasing glutathione disulfide (GS-SG) as the by-product. A simplified representation is shown below:

== Adverse effects == Although avanafil is generally well tolerated, dose dependent adverse effects can occur. The most common adverse effects include headache, flushing, nasopharyngitis, nasal congestion, and back pain. While it is also uncommon, there is a potential for visual disturbances to occur in patients, as well as hearing impairment.

=== Intake === In the developed world, the estimated daily intake of CoQ10 has been determined at 3–6 mg per day, derived primarily from meat. South Koreans have an estimated average daily CoQ (Q9 + Q10) intake of 11.6 mg/d, derived primarily from kimchi.

The German Democratic Republic (East Germany) was a Marxist-Leninist communist state that utilised a planned economy based on economic policies set by the ruling Socialist Unity Party of Germany (SED). The vast majority of the economy belonged to state-owned enterprises known as Volkseigene Betriebe (VEBs), which were under the control of the State Planning Commission of the Council of Ministers. The SED allocated investment into certain industries based on its economic policies, rather than based on the supply and demand of the market. While East Germany was able to maintain a modest economic growth and an increase in living standards, it was unable to keep pace with the spending growth of the welfare state needed to maintain those living standards. A growing proportion of investment funds were consumed by the ever-expanding and costly welfare state. The SED attempted to fuel economic growth with foreign loans, but the economy actually headed towards stagnation and led to a severe debt crisis that only starved East German industries even further. By the time of Die Wende and the fall of the SED regime in 1989, East Germany's industries were significantly labour intensive and underdeveloped compared to those in the Federal Republic of Germany (West Germany), which made many of them unprofitable and indebted. The de Maizière cabinet, the first non-socialist government of East Germany, decided on a mass privatisation of these industries.

On July 22, 2024, the company announced via press release that A&W Food Services of Canada and the A&W Revenue Royalties Income Fund "have agreed to a strategic combination," which will lead to a new publicly traded QSR franchisor entitled A&W Food Services NewCo. The transaction was expected to close in October 2024, pending approval of the TSX and regulatory approval under the Competition Act (Canada).

Sources: en.wikipedia.org

Frequently asked questions

How is SR9009 detected?

It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.

What is known about its stability?

The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.

Why does solubility matter?

Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.

What is SR9009?

It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.

Network